Definium Therapeutics, Inc. (DFTX)
17.13
-0.14
(-0.81%)
USD |
NASDAQ |
Feb 20, 16:00
17.30
+0.17
(+0.99%)
After-Hours: 20:00
Definium Therapeutics SG&A Expense (Quarterly) : 14.69M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Pulse Biosciences, Inc. | 7.33M |
| RxSight, Inc. | 27.34M |
| Plus Therapeutics, Inc. | 3.443M |
| Viridian Therapeutics, Inc. | 24.32M |
| Nutriband, Inc. | 3.492M |